skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: Base de dados/Biblioteca: Academic Search Premier (EB_SDU_P3) remover assunto: Middle Aged remover Cancer Investigation remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma
A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma

Held, Lauren A. ; Rizzieri, David ; Long, Gwynn D. ; Gockerman, Jon P. ; Diehl, Louis F. ; Castro, Carlos M. de ; Moore, Joseph O. ; Horwitz, Mitchell E. ; Chao, Nelson J. ; Gasparetto, Cristina

Cancer investigation, 2013-03, Vol.31 (3), p.172-176 [Periódico revisado por pares]

New York, NY: Informa Healthcare

Texto completo disponível

Citações Citado por
2
Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors
Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors

Rizzieri, David A. ; Crout, Christopher ; Storms, Robert ; Golob, Jared ; Long, Gwynn D. ; Gasparetto, Cristina ; Sullivan, Keith M. ; Horwitz, Mitchell ; Chute, John ; Lagoo, Anand S. ; Morris, Ashley ; Beaven, Anne ; Yang, Yiping ; Peterson, Bercedis ; Li, Zhiguo ; Chao, Nelson J.

Cancer investigation, 2011-01, Vol.29 (1), p.56-61 [Periódico revisado por pares]

England: Informa Healthcare

Texto completo disponível

Citações Citado por
3
Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy
Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Overcoming Drug Resistance in Mantle Cell Lymphoma Using a Combination of Dose-Dense and Intense Therapy

Crout, Christopher A. ; Koh, Liang-Piu ; Gockerman, Jon P. ; Moore, Joseph O. ; DeCastro, Carlos ; Long, Gwynn D. ; Diehl, Louis ; Gasparetto, Christina ; Niedzwiecki, Donna ; Edwards, Jon ; Prosnitz, Leonard ; Horwitz, Mitchell ; Chute, Jon ; Morris, Ashley ; Davis, Patricia ; Beaven, Anne ; Chao, Nelson J. ; Ali-Osman, Francis ; Rizzieri, David A.

Cancer investigation, 2010-06, Vol.28 (6), p.654-660 [Periódico revisado por pares]

England: Informa UK Ltd

Texto completo disponível

Citações Citado por
4
A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas
A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas
Material Type:
Artigo 		Adicionar ao Meu Espaço

A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas

Kujawski, Lisa A. ; Longo, Walter L. ; Williams, Eliot C. ; Turman, Nancy J. ; Brandt, Nancy ; Mosher, Deane F. ; Eickhoff, Jens C. ; Kahl, Brad S.

Cancer investigation, 2007-01, Vol.25 (2), p.87-93 [Periódico revisado por pares]

England: Informa UK Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.